Cargando…
272 Gender and Different Prevalence in Asthma Treatment With Anti-IGE (Omalizumab)
BACKGROUND: General opinion on pathogenesis and prevalence of bronchial asthma indicates that age and sex are the major risk factors. Detailed physiological mechanisms of the changing sex ratio are not fully known. AIMS AND OBJECTIVES: Investigate the influence the asthmatic patients treated with an...
Autores principales: | Patella, Vincenzo, Florio, Giovanni, Oricchio, Carmine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization Journal
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512610/ http://dx.doi.org/10.1097/01.WOX.0000412029.54630.1c |
Ejemplares similares
-
279 Near-Fatal Asthma Treated with Omalizumab
por: Contreras Contreras, Elvia Angelica, et al.
Publicado: (2012) -
282 Successful Treatment of Severe Nonallergic Asthma by Omalizumab. An Observation
por: Bergmann, Karl-Christian, et al.
Publicado: (2012) -
270 Clinical Experience in Allergic Asthma Patients: Omalizumab with Immunotherapy
por: Yalcin, Arzu Didem, et al.
Publicado: (2012) -
155 Omalizumab Improves Asthma but not Nasal Symptoms in Japanese Patients With Severe Allergic Asthma and Rhinitis
por: Nishihara, Fuyumi, et al.
Publicado: (2012) -
299 Association of Asthma and IGE Levels
por: Torres, Joselit, et al.
Publicado: (2012)